TMA MyoCon 2025TMA’s Global Myositis Patient Conference – Registration Rates Increase July 1!Register Now!

New Year’s Non-resolutions

Does the idea of New Year Resolutions stress you out? Here are some alternatives to this tradition that can add value to your year ahead without adding extra pressure.

Continue Reading

Vamorolone approved by FDA

Recently, the FDA announced the approval of a new drug, vamorolone, as a treatment for Duchenne muscular dystrophy (DMD), a genetic muscle disease that usually affects young boys. Understandably, this…

Continue Reading

IBM patients battle for veterans benefits

Recently, two members of TMA’s Military Veterans with Myositis Affinity Group were successful in acquiring disability benefits from the Veterans Administration. These benefits are significant. Not only are these former…

Continue Reading

Paula Eichenbrenner joins TMA

Starting November 29, 2023, TMA will have a new executive director. After a months-long national search, TMA’s Board of Directors has found the perfect candidate to serve as TMA’s executive…

Continue Reading